Literature DB >> 30142426

Hepatitis B virus genome recycling and de novo secondary infection events maintain stable cccDNA levels.

Chunkyu Ko1, Anindita Chakraborty2, Wen-Min Chou1, Julia Hasreiter1, Jochen M Wettengel1, Daniela Stadler1, Romina Bester1, Theresa Asen1, Ke Zhang1, Karin Wisskirchen1, Jane A McKeating3, Wang-Shick Ryu4, Ulrike Protzer5.   

Abstract

BACKGROUND & AIMS: Several steps in the HBV life cycle remain obscure because of a lack of robust in vitro infection models. These steps include particle entry, formation and maintenance of covalently closed circular (ccc) DNA, kinetics of gene expression and viral transmission routes. This study aimed to investigate infection kinetics and cccDNA dynamics during long-term culture.
METHODS: We selected a highly permissive HepG2-NTCP-K7 cell clone engineered to express sodium taurocholate co-transporting polypeptide (NTCP) that supports the full HBV life cycle. We characterized the replication kinetics and dynamics of HBV over six weeks of infection.
RESULTS: HBV infection kinetics showed a slow infection process. Nuclear cccDNA was only detected 24 h post-infection and increased until 3 days post-infection (dpi). Viral RNAs increased from 3 dpi reaching a plateau at 6 dpi. HBV protein levels followed similar kinetics with HBx levels reaching a plateau first. cccDNA levels modestly increased throughout the 45-day study period with 5-12 copies per infected cell. Newly produced relaxed circular DNA within capsids was reimported into the nucleus and replenished the cccDNA pool. In addition to intracellular recycling of HBV genomes, secondary de novo infection events resulted in cccDNA formation. Inhibition of relaxed circular DNA formation by nucleoside analogue treatment of infected cells enabled us to measure cccDNA dynamics. HBV cccDNA decayed slowly with a half-life of about 40 days.
CONCLUSIONS: After a slow infection process, HBV maintains a stable cccDNA pool by intracellular recycling of HBV genomes and via secondary infection. Our results provide important insights into the dynamics of HBV infection and support the future design and evaluation of new antiviral agents. LAY
SUMMARY: Using a unique hepatocellular model system designed to support viral growth, we demonstrate that hepatitis B virus (HBV) has remarkably slow infection kinetics. Establishment of the episomal transcription template and the persistent form of the virus, so called covalently closed circular DNA, as well as viral transcription and protein expression all take a long time. Once established, HBV maintains a stable pool of covalently closed circular DNA via intracellular recycling of HBV genomes and through infection of naïve cells by newly formed virions.
Copyright © 2018 European Association for the Study of the Liver. All rights reserved.

Entities:  

Keywords:  HBV; Hepatitis B virus; Intracellular recycling; NTCP; Replenishment; Transmission; Viral spread; cccDNA

Mesh:

Substances:

Year:  2018        PMID: 30142426      PMCID: PMC7611400          DOI: 10.1016/j.jhep.2018.08.012

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  30 in total

1.  Morphogenetic and regulatory effects of mutations in the envelope proteins of an avian hepadnavirus.

Authors:  J Summers; P M Smith; M J Huang; M S Yu
Journal:  J Virol       Date:  1991-03       Impact factor: 5.103

Review 2.  Molecular biology of hepatitis B virus infection.

Authors:  Christoph Seeger; William S Mason
Journal:  Virology       Date:  2015-03-07       Impact factor: 3.616

3.  Formation of hepatitis B virus covalently closed circular DNA: removal of genome-linked protein.

Authors:  Weifan Gao; Jianming Hu
Journal:  J Virol       Date:  2007-04-04       Impact factor: 5.103

4.  Kinetics of hepadnavirus loss from the liver during inhibition of viral DNA synthesis.

Authors:  Y Zhu; T Yamamoto; J Cullen; J Saputelli; C E Aldrich; D S Miller; S Litwin; P A Furman; A R Jilbert; W S Mason
Journal:  J Virol       Date:  2001-01       Impact factor: 5.103

5.  Hepatitis B virus infection initiates with a large surface protein-dependent binding to heparan sulfate proteoglycans.

Authors:  Andreas Schulze; Philippe Gripon; Stephan Urban
Journal:  Hepatology       Date:  2007-12       Impact factor: 17.425

6.  Residues Arg703, Asp777, and Arg781 of the RNase H domain of hepatitis B virus polymerase are critical for viral DNA synthesis.

Authors:  Chunkyu Ko; Youn-Chul Shin; Woo-Jin Park; Seungtaek Kim; Jonghwa Kim; Wang-Shick Ryu
Journal:  J Virol       Date:  2013-10-16       Impact factor: 5.103

7.  Generation of covalently closed circular DNA of hepatitis B viruses via intracellular recycling is regulated in a virus specific manner.

Authors:  Josef Köck; Christine Rösler; Jing-Jing Zhang; Hubert E Blum; Michael Nassal; Christian Thoma
Journal:  PLoS Pathog       Date:  2010-09-02       Impact factor: 6.823

8.  HBV core protein allosteric modulators differentially alter cccDNA biosynthesis from de novo infection and intracellular amplification pathways.

Authors:  Fang Guo; Qiong Zhao; Muhammad Sheraz; Junjun Cheng; Yonghe Qi; Qing Su; Andrea Cuconati; Lai Wei; Yanming Du; Wenhui Li; Jinhong Chang; Ju-Tao Guo
Journal:  PLoS Pathog       Date:  2017-09-25       Impact factor: 6.823

9.  Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus.

Authors:  Huan Yan; Guocai Zhong; Guangwei Xu; Wenhui He; Zhiyi Jing; Zhenchao Gao; Yi Huang; Yonghe Qi; Bo Peng; Haimin Wang; Liran Fu; Mei Song; Pan Chen; Wenqing Gao; Bijie Ren; Yinyan Sun; Tao Cai; Xiaofeng Feng; Jianhua Sui; Wenhui Li
Journal:  Elife       Date:  2012-11-13       Impact factor: 8.140

10.  A robust cell culture system supporting the complete life cycle of hepatitis B virus.

Authors:  Eleftherios Michailidis; Jonathan Pabon; Kuanhui Xiang; Paul Park; Vyas Ramanan; Hans-Heinrich Hoffmann; William M Schneider; Sangeeta N Bhatia; Ype P de Jong; Amir Shlomai; Charles M Rice
Journal:  Sci Rep       Date:  2017-11-30       Impact factor: 4.379

View more
  66 in total

Review 1.  Hepatitis B virus cccDNA: Formation, regulation and therapeutic potential.

Authors:  Yuchen Xia; Haitao Guo
Journal:  Antiviral Res       Date:  2020-05-22       Impact factor: 5.970

Review 2.  HBV replication inhibitors.

Authors:  Claire Pierra Rouviere; Cyril B Dousson; John E Tavis
Journal:  Antiviral Res       Date:  2020-05-05       Impact factor: 5.970

3.  T cell receptor grafting allows virological control of Hepatitis B virus infection.

Authors:  Karin Wisskirchen; Janine Kah; Antje Malo; Theresa Asen; Tassilo Volz; Lena Allweiss; Jochen M Wettengel; Marc Lütgehetmann; Stephan Urban; Tanja Bauer; Maura Dandri; Ulrike Protzer
Journal:  J Clin Invest       Date:  2019-04-30       Impact factor: 14.808

4.  Cellular DNA Topoisomerases Are Required for the Synthesis of Hepatitis B Virus Covalently Closed Circular DNA.

Authors:  Muhammad Sheraz; Junjun Cheng; Liudi Tang; Jinhong Chang; Ju-Tao Guo
Journal:  J Virol       Date:  2019-05-15       Impact factor: 5.103

Review 5.  Revisiting Hepatitis B Virus: Challenges of Curative Therapies.

Authors:  Jianming Hu; Ulrike Protzer; Aleem Siddiqui
Journal:  J Virol       Date:  2019-09-30       Impact factor: 5.103

6.  Characterization of the Termini of Cytoplasmic Hepatitis B Virus Deproteinated Relaxed Circular DNA.

Authors:  Dawei Cai; Ran Yan; Jerry Z Xu; Hu Zhang; Sheng Shen; Bidisha Mitra; Alexander Marchetti; Elena S Kim; Haitao Guo
Journal:  J Virol       Date:  2020-12-09       Impact factor: 5.103

7.  A New Role for Capsid Assembly Modulators To Target Mature Hepatitis B Virus Capsids and Prevent Virus Infection.

Authors:  Chunkyu Ko; Romina Bester; Xue Zhou; Zhiheng Xu; Christoph Blossey; Julia Sacherl; Florian W R Vondran; Lu Gao; Ulrike Protzer
Journal:  Antimicrob Agents Chemother       Date:  2019-12-20       Impact factor: 5.191

8.  Cre/LoxP-HBV plasmids generating recombinant covalently closed circular DNA genome upon transfection.

Authors:  Robert L Kruse; Xavier Legras; Mercedes Barzi
Journal:  Virus Res       Date:  2020-11-06       Impact factor: 3.303

9.  Targeting Hepatitis B Virus Covalently Closed Circular DNA and Hepatitis B Virus X Protein: Recent Advances and New Approaches.

Authors:  Nicholas A Prescott; Yaron Bram; Robert E Schwartz; Yael David
Journal:  ACS Infect Dis       Date:  2019-09-27       Impact factor: 5.084

10.  RNA Helicase DDX17 Inhibits Hepatitis B Virus Replication by Blocking Viral Pregenomic RNA Encapsidation.

Authors:  Richeng Mao; Minhui Dong; Zhongliang Shen; Hu Zhang; Yuanjie Liu; Dawei Cai; Bidisha Mitra; Jiming Zhang; Haitao Guo
Journal:  J Virol       Date:  2021-09-09       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.